These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 32211964)

  • 21. The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wu R; An DA; Shi RY; Chen BH; Wu CW; Jiang M; Xu JR; Wu LM; Pu J
    Eur J Radiol; 2020 Nov; 132():109333. PubMed ID: 33068839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac MRI for clinical dilated cardiomyopathy: Improved diagnostic power via combined T1, T2, and ECV.
    Jia SQ; Lv SY; Jin YH; Zhao Y; Tian LP; Chang MM; Yan CL; Qi XL
    Radiography (Lond); 2024 May; 30(3):926-931. PubMed ID: 38657385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
    Radunski UK; Lund GK; Säring D; Bohnen S; Stehning C; Schnackenburg B; Avanesov M; Tahir E; Adam G; Blankenberg S; Muellerleile K
    Clin Res Cardiol; 2017 Jan; 106(1):10-17. PubMed ID: 27388331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic significance of T2 mapping in evaluating myocardium alterations in patients with ST segment elevation myocardial infarction].
    Cui Q; He Q; Ge X; Gao G; Liu Y; Yu J; Wang H; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Dec; 35(12):1304-1308. PubMed ID: 38149394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):18. PubMed ID: 33658040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.
    Gastl M; Gruner C; Labucay K; Gotschy A; Von Spiczak J; Polacin M; Boenner F; Kelm M; Ruschitzka F; Alkadhi H; Kozerke S; Manka R
    Open Heart; 2020; 7(1):e001152. PubMed ID: 32201584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major.
    Meloni A; Pistoia L; Positano V; De Luca A; Martini N; Spasiano A; Fotzi I; Bitti PP; Visceglie D; Alberini G; Sinagra G; Pepe A; Cademartiri F
    Eur Radiol; 2023 Feb; 33(2):1266-1276. PubMed ID: 36066735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS; Stillman AE; Davarpanah AH
    Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.
    Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G
    Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Thompson EW; Kamesh Iyer S; Solomon MP; Li Z; Zhang Q; Piechnik S; Werys K; Swago S; Moon BF; Rodgers ZB; Hall A; Kumar R; Reza N; Kim J; Jamil A; Desjardins B; Litt H; Owens A; Witschey WRT; Han Y
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):120. PubMed ID: 34689798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular magnetic resonance imaging of functional and microstructural changes of the heart in a longitudinal pig model of acute to chronic myocardial infarction.
    Stoeck CT; von Deuster C; Fuetterer M; Polacin M; Waschkies CF; van Gorkum RJH; Kron M; Fleischmann T; Cesarovic N; Weisskopf M; Kozerke S
    J Cardiovasc Magn Reson; 2021 Sep; 23(1):103. PubMed ID: 34538266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients.
    Chaikriangkrai K; Abbasi MA; Sarnari R; Dolan R; Lee D; Anderson AS; Ghafourian K; Khan SS; Vorovich EE; Rich JD; Wilcox JE; Blaisdell JA; Yancy CW; Carr J; Markl M
    JACC Cardiovasc Imaging; 2020 Jul; 13(7):1521-1530. PubMed ID: 32199848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
    Fontana M; White SK; Banypersad SM; Sado DM; Maestrini V; Flett AS; Piechnik SK; Neubauer S; Roberts N; Moon JC
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):88. PubMed ID: 23272651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI native T1 and T2 mapping of myocardial segments in hypertrophic cardiomyopathy: tissue remodeling manifested prior to structure changes.
    Huang L; Ran L; Zhao P; Tang D; Han R; Ai T; Xia L; Tao Q
    Br J Radiol; 2019 Dec; 92(1104):20190634. PubMed ID: 31613647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).
    Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC
    J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.